The International Association for the Study of Lung Cancer (IASLC) invites you to join us as a valued commercial supporter of the 2026 Targeted Therapies of Lung Cancer (TTLC) Conference, taking place February 18–21, 2026, in Huntington Beach, California.
Recognized as the premier global forum for precision medicine in lung cancer, TTLC brings together more than 1,000 international experts—including leading investigators, translational scientists, fellows, and industry leaders—to share and discuss the latest breakthroughs in targeted therapies, early-phase trials, predictive biomarkers, and emerging clinical data.
Supporting TTLC 2026 offers a rare opportunity to engage directly with thought leaders, showcase your innovations, and align your brand with a mission-driven community advancing lung cancer treatment worldwide. Explore the possibilities ahead and discover how your organization can play a vital role in shaping the future of lung cancer care.
Order Form opens Tuesday, July 22nd at 12:00pm (noon) MDT
Contact Us
For information regarding TTLC Commercial Support Opportunities, please contact:
Tessa Baxter
International Association for the Study of Lung Cancer (IASLC)
tessa.baxter@iaslc.org
Phone: +1 720 598 1952
Stay Connected
© 2025 International Association for the Study of Lung Cancer - IASLC TTLC 2026